可光切换的纳米粒子用于触发组织透和药物输送
Rong Tong1, Houman D Hemmati, Robert Langer
1Department of Chemical Engineering, Massachusetts Institute of Technology, 77 Massachusetts Avenue, Cambridge, Massachusetts 02139, USA.
Journal of the American Chemical Society
|March 6, 2012
概括
研究人员开发出智能纳米颗粒,可以在紫外线下缩小,用于向药物输送. 这项技术允许控制释放和更好的组织透,提高治疗效率.
科学领域:
- 生物材料科学 生物材料科学
- 纳米技术 纳米技术
- 药物输送系统 药物输送系统
背景情况:
- 开发先进的药物输送系统对于提高治疗疗效和减少副作用至关重要.
- 在特定地点和时间控制药物释放仍然是医学的重大挑战.
- 纳米粒子提供了增强药物递送的潜力,但在组织透和受控释放方面经常面临局限性.
研究的目的:
- 开发和描述一种具有光触发尺寸切换能力的新型纳米颗粒药物输送系统.
- 研究光异构化诱导的体积变化的机制及其对纳米粒子特性的影响.
- 评估这些纳米粒子在增强组织透和时空药物释放方面的潜力.
主要方法:
- 合成单分散纳米颗粒,其中包括螺旋和PEG化脂质.
- 使用紫外线诱导可逆尺寸变化 (150 nm 到 40 nm) 的光触发实验.
- 纳米粒子属性的表征,包括光,药物释放动力学和细胞吸收.
- 关于光诱导尺寸切换和触发药物释放的机制研究.
主要成果:
- 成功设计的纳米粒子在暴露于紫外线光线时表现出可逆体积变化.
- 证明了光交换能力,导致粒子光,并触发了细胞内药物释放.
- 由于光引起的尺寸调制,观察到增强的组织透.
- 阐明了基于光诱导的大小切换和药物释放动态的机制.
结论:
- 这种新的纳米粒子系统提供了对药物释放的精确时空控制.
- 光触发的尺寸变化增强了纳米粒子的组织透,这是治疗疾病的关键优势.
- 这项技术对包括癌症治疗在内的各种治疗应用具有重大前景.
相关概念视频
01:30Modified-Release Drug Delivery Systems: Stimuli-Activated
Stimuli-activated drug delivery systems are designed to release drugs in response to specific physical, chemical, or biological stimuli. These systems often utilize hydrogels—three-dimensional, hydrophilic polymer networks capable of swelling in aqueous environments and retaining significant fluid volumes. Upon exposure to particular stimuli, these hydrogels undergo structural transitions that allow the embedded drug to be released. Due to this adaptive behavior, such systems are also called...
01:24Site-Targeted Drug Delivery Systems: Polymeric Carriers
Polymeric carriers enhance targeted drug delivery by increasing efficacy while minimizing off-target effects. These carriers comprise a biodegradable polymeric backbone integrated with functional elements that enable targeting, improve physicochemical properties, and regulate drug release.Targeting MechanismsThe targeting ability of polymeric carriers is mediated by a homing device, which is a molecular recognition component designed to selectively bind to specific tissues or cells. Monoclonal...
01:24Modified-Release Drug Delivery Systems: Site-Targeted
Site-targeted drug delivery systems enhance therapeutic efficacy while minimizing systemic toxicity and treatment costs. Unlike conventional methods, these systems ensure precise drug delivery, improving bioavailability and reducing side effects. Targeted drug delivery is classified into three levels. First-order targeting directs drugs to the capillary beds of specific organs or tissues. Second-order targets specific cell types, such as tumor cells, using receptor-mediated interactions.